Moderna (NASDAQ:MRNA) reported quarterly earnings results on February 13, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $-2.11,…
Moderna (NASDAQ:MRNA) reported quarterly earnings results on February 13, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-2.11, beating the consensus estimate of $-2.60 by $0.49 per share. Revenue came in at $678.0M, beating the estimate of $638.9M.
Moderna's stock moved following the earnings release. The stock currently trades at $42.23 with a market capitalization of $11.6B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · MRNA
$145.55
Down: -$3.32 · -2.23%
Live quote updated
Keep reading
